Skip to main content
OpenTrials
Completed

NCT Number: NCT04264234

Management Of Placenta Previa Cases And Determination Of Hospitalization Criteria

Placenta previa cases are one of the difficult groups of patients to manage in modern obstetrics. When the literature is evaluated extensively, no clear information can be seen especially in terms of hospitalization time. Inpatient follow-up of this patients has negative effects like hospital infections in terms of the patient, workload in terms of health personnel and financial losses in terms of the country's economy. Placenta previa cases are complicated patients in which generalizations cannot be easily performed and they should be monitored at third level hospitals. In addition, care should be personalized considering the many reasons. In this study, placenta previa cases will be followed up at 28th gestational week and evaluated at 32nd week by vaginal ultrasonography and MRI and this follow-up will continue until delivery. Thus, in this study, it was aimed to determine the parameters that would allow systematic personalization of health service in this particular patient group by making risk assessment of placenta previa cases.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Ege University Hospital

Izmir, 35100, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Monitoring of placenta previa
  • To apply before the 28th week
  • To have a low-risk second trimester screening test
  • No malformation detected in the anomaly screening

Exclusion criteria

  • Multiple pregnancies
  • Pregnancy complicated with preeclampsia
  • Pregnancy complicated by gestational hypertension
  • Pregnancy complicated by gestational diabetes mellitus

Treatment and study plan

Vaginal Ultrasonography

Diagnostic Test

Placenta previa cases will be evaluated at 32nd week by vaginal ultrasonography for invasion anomaly and preterm birth.

Magnetic Resonance Imaging

Diagnostic Test

Placenta previa cases will be evaluated at 32nd week by MRI for invasion anomaly and preterm birth.

Primary outcomes

  1. The number of placental invasion pathologies

    Time frame: 1 day

    Placental invasion pathologies detected during delivery will be evaluated.

  2. The number of preterm birth

    Time frame: 1 day

    The relation between preterm birth and placental invasion pathologies will be assessed.

Sponsors and collaborators

Lead sponsor

Ege University

Other

Registry information

Important dates

Study start
2018
Primary completion
2020
Study completion
2020
First posted
Feb 11, 2020
Registry last updated
Mar 23, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.